Epidemiology of HCV infection

Current Pharmaceutical Design

Volumn 14, Issue 17, 2008, Pages 1646-1654

  Baldo, V ^a   Baldovin, T ^a   Trivello, R ^a   Floreani, Annarosa ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Epidemiology; Hepatitis C virus; High risk groups; Incidence; Prevalence

Indexed keywords

ACUTE HEPATITIS; AGING; BLOOD DONOR; BLOOD TRANSFUSION; BODY PIERCING; EPIDEMIC; EUROPE; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; ITALY; MASS SCREENING; NORTH AMERICA; OCCUPATIONAL EXPOSURE; PATIENT COUNSELING; PLACENTAL TRANSFER; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; TATTOO; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

HEPATITIS C; HUMANS; PREVALENCE; RISK FACTORS;

EID: 47349119671     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784746770     Document Type: Review

References (115)

1. The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 20-9. Review.
2. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
4. Ito S, Ito M, Cho MJ, Shimotohno K, Tajima K. Massive seroepidemiological survey of hepatitis C virus: Clustering of carriers on the southwest coast of Tsushima, Japan. Jpn J Cancer Res 1991; 82: 1-3.
5. Hayashi J, Nakashima. & Yoshimura E, Hirata M, Maeda Y, Kashiwagi S. Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan. J Gastroenterol 1994; 29: 147-51.
6. Xia GL, Liu CB, Can HL, Li S, Zhan MY, Sub CA, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Comm 1996; 5: 62-73.
7. Lei X, Shigeko N, Deng X, Wang S, Qin S, Liu L, et al. Prevalence of hepatitis C virus infection in the general population and patients with liver disease in China. Hepatol Res 1999; 14: 135-43.
8. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: A community-based study in West Bengal, India. Hepatology 2003; 37: 802-9.
9. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-162.
10. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693-6.
11. Mazzeo C, Azzaroli F, Giovanelli S, Dormi A, Festi D, Colecchia A, et al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut 2003; 52: 1030-4.
12. Albano A, Pianetti A, Biffi MR, Bruscolini F, Baffone W, Albano V, et al. Prevalence of anti-HCV in subjects of various age groups. Eur J Epidemiol 1992; 8: 309-11.
13. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology 1994; 20: 1442-9.
14. Comandini UV, Tossini G, Longo MA, Ferri F, Cuzzi G, Noto P, et al. Sporadic hepatitis C virus infection: A case-control study of transmission routes in a selected hospital sample of the general population in Italy. Scand J Infect Dis 1998; 30: 11-5.
15. Stroffolini T, Menchinelli M, Taliani G, Dambruoso V, Poliandri G, Bozza A, et al. High prevalence of hepatitis C virus infection in a small central Italian town: Lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 235-8.
16. Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: A community-based population study in northern Italy. Infection 2002; 30: 7-12.
17. Coppola RC, Masia G, Pradat P, Trepo C, Carboni G, Argiolas F, et al. Impact of hepatitis C virus infection on healthy subjects on an Italian island. J Viral Hepat 2000; 7: 130-7.
18. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Differant seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 2005; 76: 327-32.
19. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology 1997; 26: 1006-11.
20. Maggi G, Armitano S, Brambilla L, Brenna M, Cairo M, Galvani G, et al. Hepatitis C infection in an Italian population not selected for risk factors. Liver 1999; 19: 427-31.
21. Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001; 17: 41-6.
22. Maio G, d'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, et al. Hepatitis C virus infection and alanine transaminase levels in the general population: A survey in a southern Italian town. J Hepatol 2000; 33: 116-20.
23. Di Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, et al. Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission. J Med Virol 2002; 67: 339-44.
24. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, et al. Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean town. Hepatology 2005; 41:1151-9.
25. Fabris P, Baldo V, Baldovin T, Bellotto M, Rassu M, Trivello R, et al. Changing epidemiology of HCV and HBV infections in northern Italy: A survey in the general, population. J Clin Gastroenterol 2008; in press.
26. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
27. Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003; 32: 717-24.
28. Dore GJ, MacDonald M, Law MG, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. Aust Fam Physician 2003; 32: 796-8.
29. Gérard C, Delwaide J, Vaira D, Bastens B, Servais B, Wain E, et al. Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. J Med Virol 2005; 76: 503-10.
30. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47: 1-39.
31. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, et al. Changing of hepatitis C virus genotype patterns in France at the beginning i of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 2005; 12: 405-13.
32. Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, et al Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors. J Med Virol 2001; 65: 30-4.
33. Ishibashi M, Shinzawa H, Kuboki M, Tsuchida H, Takahashi T. Prevalence of inhabitants with and-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: Age-and area-related feafures. J Epidemiol 1996; 6: 1-7.
34. Bellentani S, Miglioli L, Masutti F, Saccoccio G, Tiribelli C. Epidemiology of hepatitis C virus infection in Italy: The slowly unravelling mystery. Microbes Infect 2000; 2: 1757-63.
35. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, et al. Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology 2001; 33: 248-53
36. Medhat A, Shehata M, Magder LS, Mikhail N, Abdel-Baki L, Nafeh K et al. Hepatitis C in a community in Upper Egypt: Risk factors for infection. Am J Trop Med Hyg 2002; 66: 633-8.
37. Wasley A, Miller JT, Finelli L; Centers for Disease Control and Prevention (CDC). Surveillance for acute vind hepatitis-United States, 2005. MMWR Surveill Summ 2007; 56: 1-24.
38. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36(5 Suppl 1): S30-4.
39. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III. 1996.
40. Alter MJ. Epidemiology of hepatitis C Hepatology 1997; 26(3 Suppl 1): 62S-5S.
41. Data available from: Http://www.iss.it/binary/seie/Cont/tab06_2.118 4669248.pdf downloaded on 5 November 2007.
42. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999; 29: 1596-601.
43. Griffiths J, Nix B. Modeling the hepatitis C virus epidemic in France using the temporal pattern of hepatocellular carcinoma deaths. Hepatology 2002; 35: 709-15.
44. Sagmeister M, Renner EL, Mullhaupt B, Wong JB. Simulation of hepatitis C based on a mandatory reporting system. Eur J Gastroenterol Hepatol 2002, 14: 25-34.
45. Mariano A, Tomba G, Tosti ME, Spada E, Mele A. Future burden of hepatitis C virus infection: The case of Italy. In: 41st Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria, April 26-30, 2006.
46. Okayama A, Stuver SO, Tabor E, Tachibana N, Kohara M, Mueller NE, et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002; 9: 43-51.
47. Fukuizumi K, Sata M, Suzuki H, Nakano H, Tanikawa K. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: A prospective study. Scand J Infect Dis 1997; 29: 345-7.
48. Mohamed MK, Abdel-Hamid M, Mikhail NN, Abdel-Aziz F, Medhat A, Magder LS, et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology 2005; 42: 683-7.
49. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, Ragni P, et al. Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol 2004; 74: 216-20.
50. Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-7
51. Rieske & Domula M, Liebert UG, Grulich S, Handrick W, Bierbach U, et al. Clinical aspects and epidemiology of hepatitis C in immunosuppressed children with mostly oncologic diseases. Klin Padiatr 1998; 210: 274-8.
52. Widell A, Christensson B, Wiebe T, Schalén C, Hansson HB, Allander T, et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 1999; 130: 130-4.
53. Schvarcz R, Johansson B, Nyström B, Sönnerborg A. Nosocomial transmission of hepatitis C virus. Infection 1997; 25: 74-7.
54. Lesourd F, Izopet J, Mervan C, Payen JL, Sandres K, Monrozies X, et al. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception. Hum Reprod 2000; 15: 1083-5.
55. Bronowicki JP, Venard V, Botté C, Monhoven N, Gastin I, Choné L, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337: 237-40
56. Gabriel C, Blauhut B, Greul R, Schneeweis B, Roggendorf M. Transmission of hepatitis C by ozone enrichment of autologous blood. Lancet 1996; 347: 541.
57. Massari M, Petrosillo N, Ippolito G, Solforosi L, Bonazzi L, Clementi M, et al. Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Microbiol 2001; 39: 2860-3.
58. Heinsen A, Bendtsen F, Fomsgaard A. A phylogenetic analysis elucidating a case of patient-to-patient transmission of hepatitis C virus during surgery. J Hosp Infect 2000; 46: 309-13.
59. Saginur R, Nixon J, Devries B, Bruce N, Carruthers C, Scully L, et al. Transmission of hepatitis C in a pharmacologic study, Infect Control Hosp Epidemiol 2001; 22: 697-700.
60. Desenclos JC, Bourdiol-Razès M, Rolin B, Garandeau P, Ducos J, Bréchot C, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: Possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001; 22: 701-7.
61. Comstock RD, Mallonee S, Fox JL, Moolenaar RL, Vogt TM, Perz JF, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004; 25: 576-83.
62. Macedo de Oliveira A, White KL, Leschinsky DP, Beecham BD, Vogt TM, Moolenaar RL, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005; 142: 898-902.
63. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37: 1004-10.
64. Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev 2003; 16: 546-68.
65. Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): Guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003; 27: 213-30.
66. Thorburn D, Roy K, Cameron SO, Johnston J, Hutchinson S, McCruden EA, et al. Risk of hepatitis C virus transmission from patients to surgeons: Model based on an unlinked anonymous study of hepatitis C virus prevalence in hospital patients in Glasgow. Gut 2003; 52: 1333-8.
67. Cariani E, Zonaro A, Primi D, Magni E, Incarbone C, Scalia P, et al. Detection of HCV RNA and antibodies to HCV after needle-stick injury. Lancet 1991; 337: 850.
68. Taliani G, De Bac C, Maiozzi S, Vania A, Aliquó MC. HCV transmission by fresh packed red cells from anti-HCV-negative donors. Lancet 1991; 338: 62.
69. Marranconi F, Mecenero V, Pellizzer GP, Bettini MC, Conforto M, Vaglia A, et al. HCV infection after accidental needlestick injury in health-care workers. Infection 1992; 20: 111.
70. Mizuno Y, Suzuki K, Mori M, Hayashi Y, Owaki T, Hayashi H, et al. Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. J Hosp Infect 1997; 35: 149-54.
71. Ridzon R, Gallagher K, Ciesielski C, Ginsberg MB, Robertson BJ, Luo CC, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997; 336: 919-22.
72. Norder H, Bergström A, Uhnoo I, Aldén J, Weiss L, Czajkowski J, et al. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 1998; 36: 3066-9.
73. Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hepatitis C. JAMA 2002; 287: 2406-13.
74. Cooper BW, Krusell A, Tilton RC, Goodwin R, Levitz RE. Sero-prevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992; 13: 82-5.
75. Lanphear BP, Linnemann CC Jr, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in healthcare workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 1994; 15: 745-50.
76. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. J Infect Dis 1994; 170: 1410-7.
77. Di Nardo V, Bonaventura ME, Chiaretti B, Petrosillo N, Puro V, Ippolito G. Low risk of HCV infection in health care workers. Infection 1994; 22: 115.
78. Stroffolini T, Marzolini A, Palumbo F, Novaco F, Moiraghi A, Balocchini E, et al. Incidence of non-A, non-B and HCV positive hepatitis in healthcare workers in Italy. J Hosp Infect 1996; 33: 131-7.
79. De Carli G, Puro V, Ippolito G; Studio Italiano Rischio Occupazionale da HIV Group. Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers. Infection 2003; 31(Suppl 2): 22-7.
80. William IT, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004; 38: 1592-8.
81. Esteban JI, Gómez J, Martell M, Cabot B, Quer J, Camps J, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-60.
82. Brown P. Surgeon infects patient with hepatitis C. BMJ 1999; 319: 1219.
83. Ross RS, Viazov S, Gross T, Hofmann F, Seipp HM, Roggendorf M. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000; 343: 1851-4.
84. Ross RS, Viazov S, Thormahlen M, Bartz L, Tamm J, Rautenberg P, et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: Results of a 7-year retrospective investigation. Arch Intern Med 2002; 162; 805-10.
85. Cody SH, Nainan OV, Garfein RS, Meyers H, Bell BP, Shapiro CN, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002; 162: 345-50.
86. Duckworth GJ, Heptonstall J, Aitken C. Transmission of hepatitis C virus from a surgeon to a patient. The Incident Control Team. Commun Dis Public Health 1999; 2: 188-92.
87. Bosch X. Hepatitis C outbreak astounds Spain. Lancet 1998; 351: 1415.
88. William I. Proceedings of the viral hepatitis prevention board meeting on hepatitis B, hepatitis C, and other blood-borne infections in healthcare workers. Rome, Italy, March 17-18, 2005. Viral Hepatitis 2005; 14: 2-4.
89. Gully PR, Tepper ML. Hepatitis C. CMAJ 1997; 156:1427-30.
90. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001; 165: 889-95.
91. Andersen BM, Ellekjaer EF, Ulstrup JC. Hepatitis in non-hospitalized young drug addicts. Scand J Infect Dis 1973; 5: 91-6.
92. Vickerman P, Hickman M, Judd A. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol 2007; 36: 396-405.
93. Browne R, Asboe D, Gilleece Y, Atkins M, Mandalia S, Gazzard B, et al. Sex increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Transm Infect 2004; 80: 326-7.
94. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P. et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41: 31-6.
95. Götz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men-results from contact tracing and public health implications. AIDS 2005; 19: 969-74.
96. Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006; 20: 233-40.
97. Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007; 21: 983-91.
98. Gambotti L, Batisse D, Colin-de-Verdiere N, Delaroque-Astagneau E, Desenclos JC, Dominguez S, et al. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill 2005; 10: 115-7.
99. Tovo PA, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 1997; 25: 1121-4.
100. Zanetti AR, Tanzi E, Romanò L, Zuin G, Minola E, Vecchi L, et al. A prospective study on mother-to-infant transmission of hepatitis C virus. Intervirology 1998;41: 208-12.
101. Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998; 102: 355-9.
102. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 2000; 356: 904-7.
103. European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network. BJOG 2001; 108: 371-7.
104. Mariné-Barjoan E, Berrébi A, Giordanengo V, Favre SF, Haas H, Moreigne M, et al. HCV/HIV co-infection, HCV vind load and mode of delivery: Risk factors for mother-to-child transmission of hepatitis C virus? AIDS 2007; 21: 1811-5.
105. Hayashida A, Inaba N, Oshima K, Nishikawa M, Shoda A, Hayashida S, et al. Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res 2007; 33: 417-22.
106. Roberts EA, Young L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36(Suppl 1): S106-13.
107. Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, de Martino M, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317: 437-41.
108. Mok J, Pembrey L, Tovo PA, Newell ML; European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005; 90: F156-60.
109. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005; 192: 1872-9.
110. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): A meta-analysis. Int J Epidemiol 2003; 32: 727-34.
111. Mast EE, Hwang LY, Seto DS, Nolte, FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-9.
112. Indolfi G, Azzari C, Moriondo M, Lippi F, De Martino M, Resti M. Alanine fransaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission. J Med Virol 2006; 78: 911-4
113. Dotzlaw H, Eggert M, Neeck G, Schulz M. Spots, blots, peaks and chips: proteomic approaches in autoimmune diseases. Curr Pharm Des 2006; 12(29): 3699-706.
114. Guglielmi L, Guglielmi P, Demoly P. Drug hypersensitivity: Epidemiology and risk factors. Curr Pharm Des 2006; 12(26): 3309-12.
115. Tanikawa K. Recent advances in antiviral agents: Antiviral drug discovery for hepatitis viruses. Curr Pharm Des 2006; 12(11): 1371-7